A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
Clinical trial NCT05794581 · COMPLETED
Trial details
- NCT number
- NCT05794581
- Sponsor
- Carmot Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-21
- Primary completion
- 2024-03-06
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.